New Report on Cancer Research Funding
24 September, 2014 by Petrina SmithA new report released by Cancer Australia shows where money for cancer research came from between between 2006 and 2011.
Long Hours in Low Socioeconomic Jobs Linked to Type 2 Diabetes
24 September, 2014 by Sophie BlackshawThe Lancet Diabetes and Endocrinology journal has published the results of the largest study into the field of diabetes and long working hours so far, and found that people working more than 55 hours per week in a manual or low socioeconomic job have a 30% greater risk of developing type 2 diabetes.
Public Health Association Supports Legalisation of Medical Cannabis
23 September, 2014 by Sophie BlackshawPublic Health Association of Australia (PHAA) has supported the legalisation of cannabis by launching a new organisation policy aimed at recognising the needs of seriously and terminally ill individuals.
AMA Calls on Government to Drop Plans to Slash Medicare Rebate
23 September, 2014 by Petrina SmithAMA President Associate Professor Brian Owler has called on the Federal Government to immediately drop plans to slash $5 from the Medicare rebate following the release of figures which show health spending is not growing unsustainably.
Mantis Shrimp Eyes Inspire New Cameras to Detect Cancers
23 September, 2014 by Petrina SmithThe design of new cameras that can detect a variety of cancers and visualise brain activity is being inspired by Mantis shrimp eyes.
Aboriginal Community Controlled Health Services Compared in New Report
22 September, 2014 by Petrina SmithThe Deeble Institute for Health Policy Research has published its latest evidence brief, The relative effectiveness of Aboriginal Community Controlled Health Services (ACCHS) compared with mainstream health service.
Change of Approach in Testing for Fatigue
22 September, 2014 by Sophie BlackshawWith fatigue complaints constituting about 3-7% of all presentations to general practitioners, NPS MedicineWise has launched a new program titled Back to basics for fatigue: a diagnostic approach to aid health professionals in understanding the limits and appropriate uses of fatigue-related tests.
Charity Funds Research into Alzheimer's Disease
22 September, 2014 by Petrina SmithThe University of Western Australia's Centre for Health and Ageing Research will use a donation of $150,000 from the Theodore and Isabella Wearne Charitable Trust to help find better ways to treat depression in people with Alzheimer's disease.
Dementia Awareness – September is a Time for Reflection
18 September, 2014 by Petrina SmithCommissioner for Senior Victorians, Gerard Mansour, reflects on Dementia Awareness Month. September is Dementia Awareness Month and Sunday 21 September is World Alzheimer’s Awareness Day where organisations around the world concentrate their efforts on raising awareness about Alzheimer's and dementia.
Nanopatch Vaccine Will Help WHO Fight Polio
17 September, 2014 by Sophie BlackshawWorld Health Organisation’s (WHO) battle against polio has a new weapon after joining up with Vaxxas, the biotechnology company responsible for developing revolutionary vaccine delivery method the Nanopatch.
New Chronic Pain and Drug Dependence Service in Brisbane Hospital
17 September, 2014 by Sophie BlackshawNew Brisbane service to help tackle chronic pain and pharmaceutical dependence
The Future of Disease Epidemics
16 September, 2014 by Petrina SmithThe University of Sydney's professor Eddie Holmes is encouraging Australia to take up US-style centres for disease control, after warning that the number of disease epidemics will rise in the future.
Imagine a Healthier Future Campaign Supports the MRFF
16 September, 2014 by Petrina SmithThe Medical Research Future Fund (MRFF) Action Group has launched its Imagine a Healthier Future Campaign to encourage public investment in health and medical research.
Baxter: Not all crystalloids are created equal
15 September, 2014 by Ryan MccannIV therapy should ensure optimal fluid and electrolyte balance during resuscitation and replacement therapy. Recent studies have highlighted the risks associated with the use of HES Colloids in specific patient groups, including increased need for renal replacement therapy1,2 anaphylactoid reactions3 and increased mortality.